|
1.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Polette M, Gilles C, Marchand V, et al:
Tumor collagenase stimulatory factor (TCSF) expression and
localization in human lung and breast cancers. J Histochem
Cytochem. 45:703–709. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN
and Chan HC: The involvement of HAb18G/CD147 in regulation of
store-operated calcium entry and metastasis of human hepatoma
cells. J Biol Chem. 276:46870–46877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Riethdorf S, Reimers N, Assmann V, et al:
High incidence of EMMPRIN expression in human tumors. Int J Cancer.
119:1800–1810. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Muramatsu T and Miyauchi T: Basigin
(CD147): a multifunctional transmembrane protein involved in
reproduction, neural function, inflammation and tumor invasion.
Histol Histopathol. 18:981–987. 2003.PubMed/NCBI
|
|
8.
|
Rosenthal EL, Shreenivas S, Peters GE,
Grizzle WE, Desmond R and Gladson CL: Expression of extracellular
matrix metalloprotease inducer in laryngeal squamous cell
carcinoma. Laryngoscope. 113:1406–1410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Hanata K, Yamaguchi N, Yoshikawa K, et al:
Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer)
stimulates the migration of HEp-2 human laryngeal carcinoma cells,
accompanied by increased MMP-2 production in fibroblasts. Arch
Histol Cytol. 70:267–277. 2007. View Article : Google Scholar
|
|
10.
|
Sameshima T, Nabeshima K, Toole BP, et al:
Expression of emmprin (CD147), a cell surface inducer of matrix
metalloproteinases, in normal human brain and gliomas. Int J
Cancer. 88:21–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Stenzinger A, Wittschieber D, von
Winterfeld M, et al: High extracellular matrix metalloproteinase
inducer/CD147 expression is strongly and independently associated
with poor prognosis in colorectal cancer. Hum Pathol. 43:1471–1481.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zhu S, Chu D, Zhang Y, et al:
EMMPRIN/CD147 expression is associated with disease-free survival
of patients with colorectal cancer. Med Oncol. 30:3692013.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Pan Y, He B, Song G, et al: CD147
silencing via RNA interference reduces tumor cell invasion,
metastasis and increases chemosensitivity in pancreatic cancer
cells. Oncol Rep. 27:2003–2009. 2012.PubMed/NCBI
|
|
14.
|
Lynch CC and Matrisian LM: Matrix
metalloproteinases in tumor-host cell communication.
Differentiation. 70:561–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Caudroy S, Polette M, Tournier JM, et al:
Expression of the extracellular matrix metalloproteinase inducer
(EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary
and breast lesions. J Histochem Cytochem. 47:1575–1580. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Caudroy S, Polette M, Nawrocki-Raby B, et
al: EMMPRIN-mediated MMP regulation in tumor and endothelial cells.
Clin Exp Metastasis. 19:697–702. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Biswas C, Zhang Y, DeCastro R, et al: The
human tumor cell-derived collagenase stimulatory factor (renamed
EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res.
55:434–439. 1995.PubMed/NCBI
|
|
18.
|
Menashi S, Serova M, Ma L, Vignot S,
Mourah S and Calvo F: Regulation of extracellular matrix
metalloproteinase inducer and matrix metalloproteinase expression
by amphiregulin in transformed human breast epithelial cells.
Cancer Res. 63:7575–7580. 2003.
|
|
19.
|
Guo H, Li R, Zucker S and Toole BP:
EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis,
also binds interstitial collagenase to the tumor cell surface.
Cancer Res. 60:888–891. 2000.PubMed/NCBI
|
|
20.
|
Philp NJ, Ochrietor JD, Rudoy C, Muramatsu
T and Linser PJ: Loss of MCT1, MCT3, and MCT4 expression in the
retinal pigment epithelium and neural retina of the
5A11/basigin-null mouse. Invest Ophthalmol Vis Sci. 44:1305–1311.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kirk P, Wilson MC, Heddle C, Brown MH,
Barclay AN and Halestrap AP: CD147 is tightly associated with
lactate transporters MCT1 and MCT4 and facilitates their cell
surface expression. EMBO J. 19:3896–3904. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yang JM, Xu Z, Wu H, Zhu H, Wu X and Hait
WN: Overexpression of extracellular matrix metalloproteinase
inducer in multidrug resistant cancer cells. Mol Cancer Res.
1:420–427. 2003.PubMed/NCBI
|
|
23.
|
Misra S, Ghatak S, Zoltan-Jones A and
Toole BP: Regulation of multidrug resistance in cancer cells by
hyaluronan. J Biol Chem. 278:25285–25288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Yan L, Zucker S and Toole BP: Roles of the
multifunctional glycoprotein, emmprin (basigin; CD147), in tumour
progression. Thromb Haemost. 93:199–204. 2005.PubMed/NCBI
|
|
25.
|
Kanekura T, Chen X and Kanzaki T: Basigin
(CD147) is expressed on melanoma cells and induces tumor cell
invasion by stimulating production of matrix metalloproteinases by
fibroblasts. Int J Cancer. 99:520–528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Zhu C, Pan Y, He B, et al: Inhibition of
CD147 gene expression via RNA interference reduces tumor cell
invasion, tumorigenicity and increases chemosensitivity to
cisplatin in laryngeal carcinoma Hep2 cells. Oncol Rep. 25:425–432.
2011.PubMed/NCBI
|
|
27.
|
Lochter A and Bissell MJ: An odyssey from
breast to bone: multi-step control of mammary metastases and
osteolysis by matrix metalloproteinases. APMIS. 107:128–136. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Herszenyi L, Hritz I, Lakatos G, Varga MZ
and Tulassay Z: The behavior of matrix metalloproteinases and their
inhibitors in colorectal cancer. Int J Mol Sci. 13:13240–13263.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Gallagher SM, Castorino JJ, Wang D and
Philp NJ: Monocarboxylate transporter 4 regulates maturation and
trafficking of CD147 to the plasma membrane in the metastatic
breast cancer cell line MDA-MB-231. Cancer Res. 67:4182–4189. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Le Floch R, Chiche J, Marchiq I, et al:
CD147 subunit of lactate/ H+ symporters MCT1 and hypoxia-inducible
MCT4 is critical for energetics and growth of glycolytic tumors.
Proc Natl Acad Sci USA. 108:16663–16668. 2011.
|
|
33.
|
Zou W, Yang H, Hou X, Zhang W, Chen B and
Xin X: Inhibition of CD147 gene expression via RNA interference
reduces tumor cell invasion, tumorigenicity and increases
chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett.
248:211–218. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Jia L, Wang H, Qu S, Miao X and Zhang J:
CD147 regulates vascular endothelial growth factor-A expression,
tumorigenicity, and chemosensitivity to curcumin in hepatocellular
carcinoma. IUBMB Life. 60:57–63. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Raymond E, Faivre S, Chaney S, Woynarowski
J and Cvitkovic E: Cellular and molecular pharmacology of
oxaliplatin. Mol Cancer Ther. 1:227–235. 2002.
|
|
36.
|
Virag P, Perde-Schrepler M, Fischer-Fodor
E, et al: Superior cytotoxicity and DNA cross-link induction by
oxaliplatin versus cisplatin at lower cellular uptake in colorectal
cancer cell lines. Anticancer Drugs. 23:1032–1038. 2012. View Article : Google Scholar : PubMed/NCBI
|
